Current Drug Targets
Title:Editorial (Mini-Thematic Issue: Morphological and Molecular Backgrounds for Personalized Therapies in Genitourinary Cancers)
Volume: 16 Issue: 2
Author(s): Rodolfo Montironi, Marina Scarpelli, Matteo Santoni, Antonio Lopez-Beltran and Liang Cheng
Affiliation:
Export Options
About this article
Cite this article as:
Montironi Rodolfo, Scarpelli Marina, Santoni Matteo, Lopez-Beltran Antonio and Cheng Liang, Editorial (Mini-Thematic Issue: Morphological and Molecular Backgrounds for Personalized Therapies in Genitourinary Cancers), Current Drug Targets 2015; 16 (2) . https://dx.doi.org/10.2174/138945011602150209144413
DOI https://dx.doi.org/10.2174/138945011602150209144413 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effect of Administration Route on the Biodistribution and Shedding of Replication-Deficient AAV2: A Qualitative Modelling Approach
Current Gene Therapy The Role of Capecitabine in the Management of Tumors of the Digestive System
Reviews on Recent Clinical Trials Impaired Autophagy Mediates Resistance to Low-Dose Metronomic Cyclophosphamide Chemotherapy
Clinical Cancer Drugs New Strategies Against Prostate Cancer ā Pt(II)-Based Chemotherapy
Current Medicinal Chemistry VEGF Inhibitors in Metastatic Renal Cell Carcinoma: Current Therapies and Future Perspectives
Current Clinical Pharmacology Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets
Current Genomics Third and Fourth Generation Fluoroquinolone Antibacterials: A Systematic Review of Safety and Toxicity Profiles
Current Drug Safety Targeting STEAP1 Protein in Human Cancer: Current Trends and Future Challenges
Current Cancer Drug Targets Targeting Metabolic Enzymes in Cancer ā Clinical Trials Update
Current Enzyme Inhibition Targeting Strategies for Renal Cancer Stem Cell Therapy
Current Pharmaceutical Design Soluble Epoxide Hydrolase Inhibitors and their Potential for Treatment of Multiple Pathologic Conditions
Current Medicinal Chemistry Inhibition of the VEGF/VEGFR Pathway Improves Survival in Advanced Kidney Cancer: A Systematic Review and Meta-Analysis
Current Drug Targets Antimicrobial Chitosan based Formulations with Impact on Different Biomedical Applications
Current Pharmaceutical Biotechnology GLP-1RA and SGLT2i: Cardiovascular Impact on Diabetic Patients
Current Hypertension Reviews Genetics of Bladder Malignant Tumors in Childhood
Current Genomics Bisphosphonate Anticancer Activity in Prostate Cancer and Other Genitourinary Cancers
Anti-Cancer Agents in Medicinal Chemistry Genetics of Congenital Heart Disease
Current Cardiology Reviews Anticancer Platinum (IV) Prodrugs with Novel Modes of Activity
Current Topics in Medicinal Chemistry Pulmonary Manifestations of Rheumatoid Arthritis, Psoriatic Arthritis and Peripheral Spondyloarthritis: Prevalence, Diagnostic Approach and Treatment Options
Current Rheumatology Reviews PET in Anti-Cancer Drug Development and Therapy
Recent Patents on Anti-Cancer Drug Discovery